Gene · 9900
Papers2,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 11C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults. | Mol Psychiatry | 2025 | 39367053 | PubTator, text mining | PubMed |
| Synaptic Vesicle-Related Proteins and Ubiquilin 2 in Cortical Synaptosomes Mediate Cognitive Impairment in Vascular Dementia Rats. | Mol Neurobiol | 2025 | 38990251 | PubTator, text mining | PubMed |
| The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study. | Imaging Neurosci (Camb) | 2024 | 39989611 | PubTator, text mining | PubMed |
| Structural insights into SV2A and the mechanism of racetam anticonvulsants. | Nat Struct Mol Biol | 2024 | 39578619 | PubTator, text mining | PubMed |
| Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation. | Acta Neuropathol | 2024 | 39476256 | PubTator, text mining | PubMed |
| SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes. | Alzheimers Dement | 2024 | 39475191 | PubTator, text mining | PubMed |
| An optimal estimation approach in non-response under simple random sampling utilizing dual auxiliary variable for finite distribution function. | Heliyon | 2024 | 39421381 | PubTator, text mining | PubMed |
| Synaptic vesicle protein 2-targeted doxorubicin-loaded liposome for effective neuroblastoma therapy. | Biomed Pharmacother | 2024 | 39413621 | PubTator, text mining | PubMed |
| Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study. | bioRxiv | 2024 | 39386453 | PubTator, text mining | PubMed |
Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial. | Trials | 2024 | 39363230 | PubTator, text mining | PubMed |
| Increasing the explainability and success in classification: many-objective classification rule mining based on chaos integrated SPEA2. | PeerJ Comput Sci | 2024 | 39314719 | PubTator, text mining | PubMed |
| Characteristics of ear fullness and synaptic loss in ear fullness revealed by SV2A positron emission tomographycortical. | Front Mol Neurosci | 2024 | 39309273 | PubTator, text mining | PubMed |
| GMP-compliant automated radiosynthesis of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A). | EJNMMI Radiopharm Chem | 2024 | 39254802 | PubTator, text mining | PubMed |
| Noninvasive quantification of [18F]SynVesT-1 binding using simplified reference tissue model 2. | Eur J Nucl Med Mol Imaging | 2024 | 39155309 | PubTator, text mining | PubMed |
| Alterations in DNA 5-hydroxymethylation patterns in the hippocampus of an experimental model of chronic epilepsy. | Neurobiol Dis | 2024 | 39142613 | PubTator, text mining | PubMed |
| Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging. | Neuropsychopharmacology | 2024 | 39134769 | PubTator, text mining | PubMed |
| Cerogamasus, a New Genus of Parasitinae Mites, with Description of Four New Species from China (Acari: Parasitiformes: Parasitidae). | Animals (Basel) | 2024 | 39123786 | PubTator, text mining | PubMed |
| Loss of synaptic density in nucleus basalis of meynert indicates distinct neurodegeneration in Alzheimer's disease: the RJNB-D study. | Eur J Nucl Med Mol Imaging | 2024 | 39112615 | PubTator, text mining | PubMed |
| SV2A controls the surface nanoclustering and endocytic recruitment of Syt1 during synaptic vesicle recycling. | J Neurochem | 2024 | 39091022 | PubTator, text mining | PubMed |
| Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression. | Neuropsychopharmacology | 2024 | 39039139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9900/papers?page=9